GlassScriptPhysician profile
Bassent Botros
NPI 1265987614
$16,064.23
in general payments reported to CMS, 2019-2025
28 companies · $3,392 in 2025
The $3,392 reported for 2025 was more than what 77% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $118 · 2021: $1,053 · 2022: $5,937 · 2023: $2,289 · 2024: $3,277 · 2025: $3,392.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,677 · Travel and Lodging: $4,280.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,677.45 |
| Travel and Lodging | $4,279.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,255.33 | 2022-2025 | Watchman Flx, General - Brady, Watchman Access System |
| Medtronic, INC. | $3,097.24 | 2023-2025 | Onyx Frontier, Micra, Symplicity G3 |
| Inari Medical, INC. | $2,610.14 | 2022-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Abbott Laboratories | $2,472.27 | 2021-2025 | Supera, Optis, Thoratec Heartmate 3 Lvas Implant Kit |
| Stryker Corporation | $1,375.83 | 2025 | Clottriever Bold Catheter, Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Abiomed | $816.33 | 2024-2025 | Impella |
| Novo Nordisk INC | $341.10 | 2022-2024 | |
| Shockwave Medical, INC | $286.54 | 2022-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Janssen Pharmaceuticals, INC | $251.94 | 2020-2024 | Xarelto |
| Amgen INC. | $181.13 | 2021 | |
| Cardiva Medical, INC. | $173.44 | 2022-2023 | Cardiva Vascade 6/7f Vcs, Cardiva Vascade Mvp Vvcs 6-12f |
| Terumo Medical Corporation | $136.26 | 2023 | Glidesheath Slender, Azur Cx Detachable |
| Boehringer Ingelheim Pharmaceuticals, INC. | $122.55 | 2021 | |
| Janssen Scientific Affairs, LLC | $119.85 | 2023 | Darzalex, Tecvayli |
| Becton, Dickinson and Company | $106.08 | 2024 | Hemosphere |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Truvic Medical, INC. | $100.00 | 2022 | |
| Novartis Pharmaceuticals Corporation | $99.71 | 2024-2025 | |
| Cardiovascular Systems INC. | $98.27 | 2022 | |
| Teleflex LLC | $90.81 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $76.27 | 2025 | Camzyos |
| Astrazeneca Pharmaceuticals LP | $75.00 | 2021 | |
| Philips North America LLC | $49.72 | 2022-2025 | Labosys |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $30.02 | 2022-2025 | Lifevest |
| Heartflow, INC. | $26.87 | 2025 | |
| Angiodynamics, INC. | $24.12 | 2022 | |
| Lexicon Pharmaceuticals, INC. | $18.16 | 2023 | Inpefa |
| Cordis US Corp. | $17.86 | 2023 | Zephyr |
| Avinger INC. | $11.39 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bassent Botros listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.